AT
Aditya Tolia
Private Equity Senior Analyst
OrbiMed
Private Equity Senior Analyst at OrbiMed with prior Investec and PwC banking experience.
Bio
Professional summary
Carl L. Gordon is a Managing Partner at OrbiMed, where he leads the private equity team. OrbiMed's official profile says he joined the predecessor firm in 1995 and became a founding General Partner of OrbiMed in 1998. His background includes undergraduate work in Chemistry and Physics at Harvard, a Ph.D. in Biology from MIT, work at ImClone Systems, and postdoctoral work at Rockefeller University. His profile says he looks for innovative technology and creative management teams when evaluating investments.
Investment focus
Stage, sector, and overall fit
Stage
private equityventure-backed biotechnology
Sector
biotechnologyhealthcarelife sciences
Thesis
Biotechnology companies with innovative technology and creative management teamsHealthcare private equity
Notable companies
Selected portfolio companies the partner has backed
ImClone Systems
How to approach
Framing and angles for outreach
Pitch framing
Lead with biotechnology innovation, scientific differentiation, and the strength of the management team.
Personalization hooks
- 1Biotechnology's long-term innovation potential
- 2Scientific founder or management-team quality
- 3Collaboration with management teams and other investment firms
Recent signals
What the partner has said or done recently
Official profile notes multiple appearances on the Forbes Midas List.
Background
Career, education, and skills
Career history
- OrbiMedManaging Partner (Private Equity)1998
- OrbiMed predecessorFounding General Partner1995 – 1998
- Rockefeller UniversityPostdoctoral Fellow1993 – 1995
- Imclone SystemsScientist1987 – 1988
Education
- Massachusetts Institute of TechnologyPh.D., Biology1993
- Harvard UniversityA.B., Chemistry & Physics1987
Skills
Biotech investingPrivate equityDrug discoveryBoard governanceCFA
Other partners at OrbiMed
12 more profiles
Alexis Megibow
Private Equity Associate
OrbiMed
Private Equity Associate at OrbiMed.
Ankesh Bhansali
Managing Director
OrbiMed
OrbiMed Asia Managing Director focused on healthcare private equity.
Arun Sadhanandham
Managing Director
OrbiMed
OrbiMed Asia Managing Director investing in healthcare private equity.
BC
Brendan Weber, CFA
Principal
OrbiMed
Principal on OrbiMed's Credit & Royalty team focused on structured credit and royalty financings.
CG
Carl Gordon
Managing Partner
OrbiMed
OrbiMed Managing Partner leading private equity and biotech company formation.
CN
Carter Neild
Managing Partner
OrbiMed
OrbiMed Managing Partner focused on healthcare royalties and Asia private investments.
Clay Daniel DeMarcus
Principal
OrbiMed
Principal focused on medical technology and non-therapeutics venture investing.
CS
Cooper Steputis
Private Equity / Venture Capital
OrbiMed
Healthcare private equity and venture investor with prior investment banking experience.
Daniel Ying
Executive Director
OrbiMed
OrbiMed Asia Executive Director focused on pharma and biotech investments.
David Bonita
General Partner
OrbiMed
OrbiMed General Partner and physician-investor in healthcare and therapeutics.
David Wang
Partner
OrbiMed
OrbiMed Asia Partner focused on Greater China healthcare investments.